A detailed history of Vera Bank, N.A. transactions in Amgen Inc stock. As of the latest transaction made, Vera Bank, N.A. holds 4,764 shares of AMGN stock, worth $1.26 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
4,764
Previous 4,764 -0.0%
Holding current value
$1.26 Million
Previous $1.49 Million 3.16%
% of portfolio
0.47%
Previous 0.48%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$268.87 - $324.56 $1,344 - $1,622
-5 Reduced 0.1%
4,764 $1.35 Million
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $1,278 - $1,442
5 Added 0.1%
4,769 $1.37 Million
Q3 2022

Oct 06, 2022

SELL
$224.46 - $253.15 $14,365 - $16,201
-64 Reduced 1.33%
4,764 $1.07 Million
Q4 2021

Feb 04, 2022

SELL
$198.88 - $227.6 $5,170 - $5,917
-26 Reduced 0.54%
4,828 $1.09 Million
Q3 2021

Oct 07, 2021

BUY
$212.27 - $248.7 $23,774 - $27,854
112 Added 2.36%
4,854 $1.03 Million
Q2 2021

Aug 04, 2021

BUY
$233.58 - $259.14 $5,372 - $5,960
23 Added 0.49%
4,742 $1.16 Million
Q1 2021

Apr 13, 2021

SELL
$221.91 - $258.6 $22,191 - $25,860
-100 Reduced 2.08%
4,719 $1.17 Million
Q3 2020

Oct 16, 2020

SELL
$234.65 - $260.95 $41,063 - $45,666
-175 Reduced 3.5%
4,819 $1.23 Million
Q1 2020

Apr 21, 2020

SELL
$182.24 - $241.7 $110,255 - $146,228
-605 Reduced 10.81%
4,994 $1.01 Million
Q4 2019

Jan 27, 2020

SELL
$189.21 - $243.2 $94,605 - $121,600
-500 Reduced 8.2%
5,599 $1.35 Million
Q3 2019

Oct 11, 2019

SELL
$174.11 - $208.62 $75,911 - $90,958
-436 Reduced 6.67%
6,099 $1.18 Million
Q1 2019

Apr 23, 2019

SELL
$180.87 - $203.88 $134,748 - $151,890
-745 Reduced 10.23%
6,535 $1.24 Million
Q4 2018

Feb 12, 2019

BUY
$178.4 - $208.25 $1.3 Million - $1.52 Million
7,280 New
7,280 $1.42 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Vera Bank, N.A. Portfolio

Follow Vera Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vera Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Vera Bank, N.A. with notifications on news.